
Advanced Technology, World Class Care
At UNC Medical Center, two world-class treatment programs are operating out of one procedure room, outfitted with the latest devices and interventional technology.
At UNC Medical Center, two world-class treatment programs are operating out of one procedure room, outfitted with the latest devices and interventional technology.
With funds from an international grant, Smith and colleagues are creating an instrument to visualize neuronal activity throughout the entire brain of a moving vertebrate organism.
UNC / NC State researchers devise a new nanotechnology to enhance the body’s own immune response to kill skin cancer tumors.
In a first-of-its-kind-study, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center discovered and applied a new screening technique capable of testing thousands of potential drug compounds to see if those compounds can reverse abnormal DNA unwinding in Ewing sarcoma, a bone and soft tissue cancer that’s most common in teens and young adults.
Scientists from the UNC / NC State joint biomedical engineering department are creating a new kind of research tool that will be nearly indistinguishable from the human gastrointestinal tract.
UNC’s Center for Heart & Vascular Care has been offering Transcatheter Aortic Valve Replacement (TAVR) for less than a year. In that time, the team has built a national reputation for excellence, allowing UNC to be among the first phase of the rollout of a next generation TAVR device, Evolut-R, developed by Medtronic. This valve is the first repositionable transcatheter valve ever available.
A new tool will allow David Berkoff, MD, associate professor of orthopaedics, the ability to provide his patients with more accurate diagnoses, closely monitor their recovery and, he says, aid in research.
A UNC core facility churns out radioactive agents to investigate the subcellular activity that drives disease.
Graduate student Sarah Shelton reinvented herself from a dancer to a scientist. Now, she’s creating a new ultrasound technique to improve cancer diagnostics.
Using a new ‘chemogenetic’ technique invented at UNC, scientists turn neurons ‘on’ and ‘off’ to demonstrate how brain circuits control behavior in mice. This unique tool – the first to result from the NIH BRAIN Initiative – will help scientists understand how to modulate neurons to more effectively treat diseases.
In February, UNC neurologist Hae Won Shin, MD, and neurosurgeon Eldad Hadar, MD, were the first in the state to implant the NeuroPace RNS System following the medical device’s recent FDA approval. In clinical trials, the NeuroPace system greatly reduced the number of seizures experienced by patients with severe epilepsy.
Dr. Harold Pillsbury performed the surgery to implant a newly FDA-approved device that enables wearers to have MRI scans when needed. This was not possible with earlier cochlear implant models.